Identifying methamphetamine users at risk for major depressive disorder: Findings from the methamphetamine treatment project at three-year follow-up
Identifying methamphetamine users at risk for major depressive disorder: Findings from the methamphetamine treatment project at three-year follow-up
复制标题
DOI：
10.1080/10550490701861110
复制
发表时间：
2008-03-01
影响因子：
3.7
通讯作者：
Rawson, Richard
中科院分区：
文献类型：
--
作者：
Glasner-Edwards, Suzette;Mooney, Larissa J.;Rawson, Richard
对甲基苯丙胺使用者抑郁症的危险因素知之甚少。使用的数据从526名成年人在最大的心理社会临床试验的甲基苯丙胺用户进行了迄今为止，本研究探讨了临床，人口统计学和物质使用的特点，预测存在的诊断重度抑郁症（MDD）治疗甲基苯丙胺依赖后三年。结果表明，两个风险因素预测MDD的诊断：贝克抑郁量表总分大于20，以及一个或多个先前的自杀企图。这些风险因素确定了可能受益于精神症状早期干预的甲基苯丙胺使用者。
Little is known about risk factors for depression in methamphetamine users. Using data from 526 adults in the largest psychosocial clinical trial of methamphetamine users conducted to date, this study examined clinical, demographic, and substance use characteristics that predict the presence of a diagnosis of major depressive disorder (MDD) three years after treatment for methamphetamine dependence. The results indicate that two risk factors predict a diagnosis of MDD: a Beck Depression Inventory total score greater than 20, and one or more prior suicide attempts. These risk factors identify methamphetamine users who may benefit from early interventions for psychiatric symptoms.